Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
Babjuk, M. et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur. Urol. https://doi.org/10.1016/j.eururo.2021.08.010 (2021).
Witjes, J. A. et al. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur. Urol. 79, 82–104 (2021).
Article CAS PubMed Google Scholar
Sylvester, R. J. et al. European Association of Urology (EAU) Prognostic Factor Risk Groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel. Eur. Urol. 79, 480–488 (2021).
Herbert, A. et al. Population trends in emergency cancer diagnoses: the role of changing patient case-mix. Cancer Epidemiol. 63, 101574 (2019).
Article CAS PubMed PubMed Central Google Scholar
Teoh, J. Y. et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur. Urol. 78, 893–906 (2020).
Cumberbatch, M. G. K. et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur. Urol. 74, 784–795 (2018).
Bryan, R. T. et al. A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years. BJU Int. 112, 169–175 (2013).
Richters, A. et al. Bladder cancer survival: women only fare worse in the first two years after diagnosis. Urol. Oncol. 37, 853–861 (2019).
Article CAS PubMed Google Scholar
Freedman, N. D., Silverman, D. T., Hollenbeck, A. R., Schatzkin, A. & Abnet, C. C. Association between smoking and risk of bladder cancer among men and women. J. Am. Med. Assoc. 306, 737–745 (2011).
Uhlig, A. et al. Gender specific differences in disease-free, cancer specific and overall survival after radical cystectomy for bladder cancer: a systematic review and meta-analysis. J. Urol. 200, 48–60 (2018).
Wang, S. C. et al. The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: national estimates from 33 countries. Sci. Rep. 7, 4360 (2017).
Article PubMed PubMed Central Google Scholar
Mungan, N. A. et al. Gender differences in stage-adjusted bladder cancer survival. Urology 55, 876–880 (2000).
Article CAS PubMed Google Scholar
Kluth, L. A. et al. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur. Urol. 66, 913–919 (2014).
Liu, S. et al. The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients. Int. Urol. Nephrol. 47, 951–958 (2015).
Article CAS PubMed Google Scholar
Mossanen, M. & Gore, J. L. The burden of bladder cancer care: direct and indirect costs. Curr. Opin. Urol. 24, 487–491 (2014).
NHS Digital. Cancer Survival in England, cancers diagnosed 2015 to 2019, followed up to 2020. NHS Digital https://digital.nhs.uk/data-and-information/publications/statistical/cancer-survival-in-england/cancers-diagnosed-2015-to-2019-followed-up-to-2020#resources (2022).
Catto, J. W. F. et al. Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019. BJU Int. https://doi.org/10.1111/bju.15970 (2023).
Theodorescu, D., Li, Z. & Li, X. Sex differences in bladder cancer: emerging data and call to action. Nat. Rev. Urol. 19, 447–449 (2022).
Article PubMed PubMed Central Google Scholar
Sadighian, M. & Porten, S. Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion. Curr. Opin. Urol. 29, 542–547 (2019).
Burge, F. & Kockelbergh, R. Closing the gender gap: can we improve bladder cancer survival in women? - A systematic review of diagnosis, treatment and outcomes. Urol. Int. 97, 373–379 (2016).
Koti, M. et al. Sex differences in bladder cancer immunobiology and outcomes: a collaborative review with implications for treatment. Eur. Urol. Oncol. 3, 622–630 (2020).
Shu, T. D. et al. Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database. Cancer Causes Control https://doi.org/10.1007/s10552-023-01679-x (2023).
Dong, M. et al. Sex differences in cancer incidence and survival: a pan-cancer analysis. Cancer Epidemiol. Biomark. Prev. 29, 1389–1397 (2020).
Marcos-Gragera, R. et al. Urinary tract cancer survival in Europe 1999–2007: results of the population-based study EUROCARE-5. Eur. J. Cancer https://doi.org/10.1016/j.ejca.2015.07.028 (2015).
Richters, A., Leliveld, A. M., Goossens-Laan, C. A., Aben, K. K. H. & Ozdemir, B. C. Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry. World J. Urol. 40, 2275–2281 (2022).
Article PubMed PubMed Central Google Scholar
Blindheim, A. et al. T1 bladder cancer in Norway: treatment and survival. Scand. J. Urol. 54, 370–375 (2020).
Mori, K. et al. Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis. World J. Urol. https://doi.org/10.1007/s00345-022-04116-x (2022).
Article PubMed PubMed Central Google Scholar
Dobruch, J. et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur. Urol. 69, 300–310 (2016).
Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113, 5S–13S (2002).
Zhou, Y. et al. Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review. BMJ Open 9, e029143 (2019).
Article PubMed PubMed Central Google Scholar
Bolenz, C., Schroppel, B., Eisenhardt, A., Schmitz-Drager, B. J. & Grimm, M. O. The investigation of hematuria. Dtsch. Arztebl Int. 115, 801–807 (2018).
PubMed PubMed Central Google Scholar
Lyratzopoulos, G., Abel, G. A., McPhail, S., Neal, R. D. & Rubin, G. P. Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open 3, 002861 (2013).
Ngo, B., Perera, M., Papa, N., Bolton, D. & Sengupta, S. Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review. BJU Int. 119, 10–18 (2017).
Bryan, R. T. et al. A comparative analysis of the influence of gender, pathway delays, and risk factor exposures on the long-term outcomes of bladder cancer. Eur. Urol. Focus. 1, 82–89 (2015).
Zhou, Y. et al. Prolonged diagnostic intervals as marker of missed diagnostic opportunities in bladder and kidney cancer patients with alarm features: a longitudinal linked data study. Cancers https://doi.org/10.3390/cancers13010156 (2021).
Article PubMed PubMed Central Google Scholar
Danforth, K. N. et al. Care quality and variability in the use of intravesical therapy for initial treatment of nonmuscle invasive bladder cancer within a large, diverse integrated delivery system. Urology 131, 93–103 (2019).
Grajales, V. et al. Associations between female sex and treatment patterns and outcomes for muscle-invasive bladder cancer. Urology 151, 169–175 (2021).
Marinaro, J. et al. Sex and racial disparities in the treatment and outcomes of muscle-invasive bladder cancer. Urology 151, 154–162 (2021).
Heberling, U. et al. Gender and mortality after radical cystectomy: competing risk analysis. Urol. Int. 101, 293–299 (2018).
Farber, N. J. et al. Disparities in the use of continent urinary diversions after radical cystectomy for bladder cancer. Bladder Cancer 4, 113–120 (2018).
Comments (0)